Strategic location within the Houston biotech hub provides Bristol Myers Squibb with access to a robust ecosystem of talent, infrastructure, and academic partnerships. This massive $2.3 billion investment represents a definitive shift toward securing the domestic supply chain and modernizing the
Laboratories specializing in virology and immunology must now evaluate if their current biosafety margins are sufficient to protect staff from aerosolized H5N1 exposure. The recent isolation of live, infectious H5N1 avian influenza from a commercial batch of fetal bovine serum (FBS) has sparked a
Utilizing brewery-style fermentation tanks to cultivate cocoa cells allows manufacturers to maintain 100 percent supply-chain stability regardless of unpredictable weather patterns. This innovative methodology, pioneered by Boston-based biotechnology leader GALY, arrives at a critical juncture for
Standard laboratory protocols for washing and preparing harvested stem cells must be modified with pre-warmed solutions to prevent thermal shock in sensitive biological samples. This requirement becomes critically apparent when treating patients with Cold Agglutinin Disease (CAD), a rare autoimmune
Biopharmaceutical companies in France are utilizing disposable systems to remain competitive by shortening the downtime required between different product batches. This shift represents a fundamental realignment of industrial priorities, moving away from the rigid, permanent infrastructure of the
Securing an MSCI AAA ESG rating and an EcoVadis Platinum Medal places WuXi Biologics in the top 1% of companies evaluated for environmental and social governance. This landmark achievement underscores the organization's role as a dominant force in the global healthcare market, particularly as it
